CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Cimetidine Hydrochloride In Sodium Chloride 0.9% In Plastic Container patents expire, and when can generic versions of Cimetidine Hydrochloride In Sodium Chloride 0.9% In Plastic Container launch?
Cimetidine Hydrochloride In Sodium Chloride 0.9% In Plastic Container is a drug marketed by Hospira and is included in two NDAs.
The generic ingredient in CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is cimetidine hydrochloride. There are twenty-five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cimetidine hydrochloride profile page.
Summary for CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 24 |
Clinical Trials: | 62 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assiut University | Early Phase 1 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 2 |
Beijing Biostar Pharmaceuticals Co., Ltd. | Phase 2 |
See all CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER clinical trials